Publications
- Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors2021 | Second Faculty of Medicine
- PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum2021 | Second Faculty of Medicine
- Treatment response of CNS high-grade neuroepithelial tumors with MN1 alteration2020 | Second Faculty of Medicine
- Combined immunotherapy improves outcome for replication repair deficient (RRD) high-grade glioma failing anti-PD1 monotherapy: A report from the International RRD Consortium2024 | Second Faculty of Medicine
- LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration2024 | Second Faculty of Medicine
- Clinical and molecular study of radiation-induced gliomas2024 | Second Faculty of Medicine
- Evaluation of the growth rates and related prognostic factors in radiation-induced meningiomas2023 | Second Faculty of Medicine, Central Library of Charles University, First Faculty of Medicine, Faculty of Physical Education and Sport
- Current management in the treatment of intramedullary ependymomas in children2023 | Second Faculty of Medicine, Central Library of Charles University, First Faculty of Medicine
- Predictors of postoperative complications and functional outcomes in pediatric patients with surgically treated fourth ventricle tumors2023 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification2023 | Second Faculty of Medicine
Loading network view...